The findings are yet another reminder of the remarkable and often unexpected ways that vaccines can protect us well beyond their intended role of preventing infection.
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...
FDA Commissioner Martin Makary discusses vaccine policy, COVID-era decisions and the erosion of trust in government health ...
Dr. Patricia Tibbs said her pediatric practice in Laurel has gotten “so many rejections” for newborn hepatitis B vaccines in the last year, and she suspects some of those infants may end up with ...
The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...
Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...
Findings from a phase 3 study provided additional evidence that the first pneumococcal vaccine made specifically for adults ...
COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.
If the FDA ceases to be a predictable source of regulatory guidance, then China will gain a significant advantage in the race ...
You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the ...
The FDA’s claims about COVID-19 vaccine deaths in children lack strong evidence and could restrict vaccine access. Learn why ...
New intranasal BPZE1 vaccine is safe and reduces Bordetella pertussis colonisation, offering hope for whooping cough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results